FindTrial
Sign In

The relationship between alodse reductase C-106T polymorphism and the susceptibility of essential hypertension

The relationship between alodse reductase C-106T polymorphism and the susceptibility of essential hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-RCC-14004192
Enrollment
Unknown
Registered
2014-01-23
Start date
2014-01-26
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

case:None
Control:Chinese Han healthy volunteers

Sponsors

Institute of Clinical Pharmacology, Central South University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Patients diagnosed with primary hypertension; (2) Chinese Han healthy volunteers.

Exclusion criteria

Exclusion criteria: Secondary hypertension and other disease affects blood pressure, diabetic

Design outcomes

Primary

MeasureTime frame
related gene;Blood pressure;—

Countries

China

Contacts

Public ContactDong-sheng OUYANG

Institute of Clinical Pharmacology, Central South University

ouyangyj@163.com+86 13307313736

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026